This bill allocates state funding to support the operation of Pennsylvania's professional licensure boards and the State Athletic Commission for the 2026-2027 fiscal year. It provides $68.4 million from the Professional Licensure Augmentation Account to the Department of State's Bureau of Professional and Occupational Affairs, along with separate restricted funds totaling approximately $13.5 million for the State Boards of Medicine, Osteopathic Medicine, Podiatry, and the State Athletic Commission. The legislation ensures these organizations have the necessary resources to carry out their licensing and regulatory functions without treating these funds as general government appropriations.
SB 49 establishes Pennsylvania's Cannabis Control Board to regulate medical cannabis, replacing the prior oversight structure under the 2016 Medical Marijuana Act. The board will manage permits for cannabis organizations (including warehousing, distribution, and transport), oversee dispensing to registered medical patients and caregivers, and administer a Cannabis Regulation Fund. Key provisions include defining cannabis products (excluding industrial hemp), setting THC limits, and requiring board meetings and public records. This bill directly affects medical cannabis organizations, patients, and caregivers by creating a centralized regulatory system for their operations.
SB 507 amends Pennsylvania's medical licensing law to reestablish the State Board of Medical Education and Licensure as the State Board of Medicine and update its structure. It directly affects midwifery professionals by creating three new license categories: midwifery, nurse-midwife, and certified midwife. The bill establishes specific requirements and definitions for these licenses under the board's authority. This change clarifies licensing pathways for midwifery practitioners within the state's medical regulatory framework. The bill passed final passage on October 21, 2025.
SB 998 would create a grant program to fund expansions of nursing education programs at colleges and universities. It requires the Department of Community and Economic Development to administer grants for institutions aiming to increase nursing program capacity, directly affecting nursing schools and future nursing students. Key provisions include establishing grant criteria, application processes, and reporting requirements for funded programs. The bill is currently pending in the Appropriations committee after committee review.
SB 1211 amends Pennsylvania's Insurance Company Law of 1921 to require casualty insurance policies to cover biomarker testing for medical assistance and Children's Health Insurance Program enrollees. The bill defines medical assistance and CHIP managed care plans as health care plans that use gatekeepers to manage services, explicitly including biomarker testing in this definition. This change ensures that insurance coverage for these specific health services is standardized under state law, subject to necessary federal approval. The legislation takes effect 60 days after passage.
SB 804 amends Pennsylvania's health and safety laws to ban the intentional addition of DEHP and certain ortho-phthalates (like BBP, DBP, DINP) in medical devices. It specifically targets intravenous (IV) solution containers (like IV bags) and IV tubing used in hospitals and healthcare facilities. The bill prohibits manufacturers from adding these chemicals to medical devices if they serve a functional purpose, requiring notice of such additions. This affects device manufacturers and healthcare facilities purchasing these products, directly changing manufacturing standards for common medical equipment.
SB 614 amends Pennsylvania's Fiscal Code to establish a state-funded initiative supporting workforce development for Federally Qualified Health Centers (FQHCs), which are community health centers serving rural and underserved areas. The bill directly affects FQHCs by providing funding to recruit and retain primary care staff, addressing documented shortages in these facilities. Key provisions include creating a dedicated funding stream within the state budget specifically for FQHC workforce expansion, with appropriations to cover hiring and training costs. This policy change aims to strengthen primary care access in communities with limited healthcare resources through targeted financial support.
HB 923 amends the State Lottery Law to redirect lottery revenue toward providing pharmaceutical assistance for elderly residents. It directly affects seniors who qualify for prescription drug aid under state programs by modifying eligibility determination procedures. The key provision updates how income and asset thresholds are calculated to determine who qualifies for this assistance. The bill became law on November 24, 2025, after approval by both legislative chambers and the governor.
SB 88 amends Pennsylvania's Insurance Company Law to require health insurance plans sold in the state to cover specific breast imaging services without cost-sharing for policyholders. It mandates annual mammograms for women 40+ and physician-recommended mammograms for women under 40, plus MRI and other breast imaging for those at average or higher risk of breast cancer due to factors like family history, genetic mutations, or dense breast tissue. The law specifies coverage for screening, supplemental, and diagnostic exams but does not require coverage for mastectomies or override standard deductibles/copays beyond the minimum required services. This replaces prior requirements that allowed cost-sharing and excluded MRI coverage.
SB 715 extends the expiration date of Pennsylvania's Rare Disease Advisory Council from June 30, 2025, to June 30, 2028. This procedural bill directly affects the council, which advises state departments on rare disease issues, and the departments it collaborates with (Health, Insurance, Human Services, Education). The key provision simply changes the expiration date in the 2017 law without altering the council's structure or duties. This extension provides continued operation of the council for an additional three years.
